Evolus, Inc. (EOLS)
6.445
-0.14
(-2.20%)
USD |
NASDAQ |
May 21, 16:00
6.445
0.00 (0.00%)
After-Hours: 19:59
Evolus EPS Diluted (Quarterly) : -0.1638 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viatris, Inc. | 0.1501 |
| Talphera, Inc. | -0.0366 |
| Kaya Holdings, Inc. | -0.0581 |
| BioStem Technologies, Inc. | -0.5234 |
| Nascent Pharma Holdings, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.67M |
| Revenue (Quarterly) | 73.14M |
| Total Expenses (Quarterly) | 83.81M |
| Enterprise Value | 549.09M |
| Gross Profit Margin (Quarterly) | 64.75% |
| Profit Margin (Quarterly) | -14.59% |
| Earnings Yield | -10.40% |
| Normalized Earnings Yield | -11.59 |